20 articles, transcripts, and reports
Bristol Myers Squibb (NYSE: BMY) reported second quarter 2022 earnings results today. Total revenue grew 2% year-over-year to $11.9 billion. Net earnings attributable to BMY…
Bristol Myers Squibb (NYSE: BMY) reported fourth quarter 2021 earnings results today. Total revenues increased 8% year-over-year to $12 billion, driven by Eliquis, Immuno-Oncology and…
Bristol-Myers Squibb Company (NYSE: BMY) Thursday reported stronger-than-expected fourth-quarter results. The company’s stock gained in the pre-market session soon after the announcement. The pharmaceutical company…
Pharmaceutical firm Bristol-Myers Squibb Company (NYSE: BMY) reported second-quarter 2020 financial results on Thursday morning. The results were better than analysts’ expectations. Revenues surged 61%…
Bristol-Myers Squibb Co (BMY) Q1 2020 earnings call dated May. 07, 2020 Corporate Participants: Timothy Power — Vice President, Investor Relations Giovanni Caforio — Chairman of the Board and…
Bristol-Myers Squibb Company (NYSE: BMY) reported first-quarter 2020 financial results before the regular trading hours on Thursday. The results were better than analysts’ expectations. CEO…
Bristol-Myers Squibb Company (NYSE: BMY) slipped to a loss in the fourth quarter of 2019 from a profit last year, due to the amortization of…
After closing the high-value acquisition of Celgene a few months ago, Bristol-Myers Squib (NYSE: BMY) will be publishing its fourth-quarter results on Thursday before the…
Driven by the strong sales of leading products, earnings of Bristol-Myers Squibb (NYSE: BMY) increased in the third quarter and exceeded the market’s projection. Total…
Bristol-Myers Squibb (NYSE: BMY) will be publishing its September-quarter earnings Thursday before the opening bell. The bio-pharmaceutical company is expected to earn $1.07 per share…
